Company RegeneRx Biopharmaceuticals Inc OTC Bulletin Board
Equities
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Novel Molecules
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -.--% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -.--% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 86 | 12/05/82 | |
J. Finkelstein
CEO | Chief Executive Officer | 72 | 31/12/83 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
J. Finkelstein
CEO | Chief Executive Officer | 72 | 31/12/83 |
Founder | 86 | 12/05/82 | |
Joe McNay
BRD | Director/Board Member | 90 | 31/12/01 |
Mauro Bove
BRD | Director/Board Member | 69 | 31/12/03 |
R. Elsey
BRD | Director/Board Member | 71 | 31/08/10 |
Director/Board Member | 66 | 31/03/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,496,966 | 836,249 ( 55.86 %) | 0 | 55.86 % |
Company contact information
RegeneRx Biopharmaceuticals, Inc.
15245 Shady Grove Road Suite 470
20850, Rockville
+
http://www.regenerx.comSector
1st Jan change | Capi. | |
---|---|---|
-3.75% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |